Publication of all manuscripts regarding the ICIS Expert Meeting September 22-24, 2022 in Lenzerheide, Switzerland
British Journal of Hemaology Wiley Online Library
Antibody Therapy Substitution- Immunomodulation- Monoclonal Immunotherapy: Imbach, Paul (Ed.)
The Clinical Translation of Intravenous Immunoglobulin from Substitution to Immunomodulation In: Imbach P. Antibody Therapy. Substitution – Immunomodulation – Monoclonal Immunotherapy. Springer Verlag, Berlin, Heidelberg 2018;1-14
Imbach P.
Manual of Primary and Secondary Immunodeficiencies, In: Imbach P. Antibody Therapy. Substitution – Immunomodulation – Monoclonal Immunotherapy. Springer Verlag, Berlin, Heidelberg 2018;23-33
Imbach P.
Manual of Intravenous and Subcutaneous IgG Indications in Autoimmune Diseases, In: Imbach P. Antibody Therapy. Substitution – Immunomodulation – Monoclonal Immunotherapy. Springer Verlag, Berlin, Heidelberg 2018;35-60
Imbach P.
Registries in immune thrombocytopenia: The history of the Intercontinental Cooperative ITP Study Group. In: Imbach P. Antibody Therapy. Substitution – Immunomodulation – Monoclonal Immunotherapy. Springer Verlag, Berlin, Heidelberg 2018;277-287
Kühne T.
Supplement to Seminars in Hematology on the 5th Intercontinental Cooperative ITP Study Group (ICIS) Expert Meeting in Flüeli-Ranft, Switzerland, September 2015 Volume 53, Supplement 1, Pages A1-A4, S1-S72 (April 2016)
Supplement to Seminars in Hematology on the 4th Intercontinental Cooperative ITP Study Group (ICIS) Expert Meeting in Montreux, Switzerland, September 2012 Vol. 50 January, 2013 p.S1-S126, Supplement 1
Paul Imbach, M.D., and Mark Crowther, M.D.
The Special Issue of Pediatric Blood & Cancer on the 2nd Intercontinental Cooperative ITP Study Group (ICIS) Expert Meeting on „Critical Issues and Future Research of ITP“, September 16-18, 2006, in Yverdon-les-Bains, Switzerland. Pediatric Blood & Cancer 2006, Volume 47, Issue S5, p 649- 745.
Kühne T
Editorial 2nd Expert Meeting 2006 on critical issues and future development of research in ITP
Kühne T
Idiopathic thrombocytopenic purpura in childhood, controversies and solutions
Ruggeri M.
Heterogeneity of terminology and clinical definitions in adult idiopathic thrombocytopenic purpura in childhood: A critical appraisal from literature analysis
Hazzan R
Risk factors for future development of systemic lupus erythematosus in children with idiopathic thrombocytopenic purpura
Nilsson C
Studies of chronic ITP in children and adolescents
Roganovic J
Idiopathic thrombocytopenic purpura: A 15year natural history study at the Children’s Hospital Rijeka, Croatia
Baronci C
Idiopathic thrombocytopenic purpura (ITP) in children
Gaedicke G
Some unsettled questions in childhood thrombocytopenia caused by immunologic platelet destruction (acute and chronic ITP)
Culic S
Correlations among age, cytokines, lymphocyte subtypes, and platelet counts in autoimmune thormbocytopenic purpura
Sood R
Gene expression profile in idiopathic thrombocytopenic purpura (ITP)
Rischewski J
Idiopathic Thrombocytpenic Purpura (ITP): Is there a genetic predisposition?
Buchanan G
Current challenges in the management of children with idiopathic thrombocytopenic purpura
Imbach P
Development and Research in idiopathic thrombocytopenic purpura An inflammatory and autoimmune disorder
Bessho F
Guideline of management for childhood ITP
Mackensen S
Development of a disease-specific auality of life questionnaire for children & adolescents with idiopathic thrombocytopenic purpura (ITP-QoL)
Wainwright RD
Psychosocial aspects of immune thrombocytopenia and secondary human immunodeficiency virus-related pediatric immune thrombocytopenia in the Republic of South Africa
Panzer S
Flow cytometric evaluation of platelet activation in chronic autoimmune thrombocytopenia
Tomer A
Autoimmune thrombocytopenia: Determination of platelet specific autoantibodies by flow cytometry
Salama A
A novel agglutination test for antigen-specific detection of platelet antibodies
Koene H
Critical issues of current and future developments in the treatment of immune thrombocytopenic purpura
Bennett C
Targeted ITP strategies: do they elucidate the biology of ITP and related disorders?
Crow A
Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia
Tamminga R
Rituximab treatment for symptomatic chronic ITP
Kjaersgaard M
A review of anti-D treatment of childhood idiopathic thrombocytopenic purpura
Meyer O
Replacement of intravenous administration of anti-D by subcutaneous administration in patients with autoimmune thrombocytopenia
Nichol J
AMG 531: An investigational thrombopoiesis-stimulating peptibody (TSP)
Miale T
Multimodal management including precisely targeted irradiation in a severe refractory case of Evans Syndrome
Wrobel G
Experiences with recombinant activated factor VII in the treatment of severe, refractory thrombocytopenia
El Alfy M
Prospective evaluation of high cost management of severe chronic ITP in children and adolescents < 16 years
Minkov M
Critical issues concerning splenectomy for chronic idiopathic thrombocytopenic purpura in childhood
Donato H
Splenectomy and spontaneous remission in children with chronic idiopathic thrombocytopenic purpura
Kaplinsky C
Post-splenectomy antibiotic prophylaxis unfinished story: To treat or not to treat?
Ramenghi U
Splenectomy in children with chronic ITP: Long-term efficacy and relation between its outcome and responses to previous treatments
Immune Thrombocytopenia (ITP) (Editor). UNI-MED Verlag Bremen, London, Boston, 2010, 2nd edition 2013 Kühne T.
Editorial 3rd Intercontinental Cooperative ITP Study Group (ICIS) Expert Meeting in Basel, Switzerland, September 2009
Thomas Kühne and Paul Imbach
Editorial 3rd Intercontinental Cooperative ITP Study Group (ICIS) Expert Meeting in Basel, Switzerland, September 2009
Clemetson KJ, Panzer S
The working group for basic science in ITP at the International Cooperative ITP Study Group (ICIS)
Tamary H, Roganovic J et al.
Consensus PaperICIS Expert Meeting Basel 2009 treatment milestones in immune thrombocytopenia
Grainger JD, Bolton-Maggs PHB et al.
Diagnosis and management of chronic ITP: comments from an ICIS expert group
Zehnder JL, Semple JW et al.
Future research in ITP: an ICIS consensus
Biburger M, Aschermann S et al.
The role of Fcγ receptors in murine autoimmune thrombocytopenia
Pang SJY, Lazarus AH
Mechanisms of platelet recovery in ITP associated with therapy
Semple JW
Animal models of immune thrombocytopenia (ITP)
Speer O, Schmugge M
Investigating caspases and other markers of apoptosis in ITP
Neunert CE
Evaluating bleeding severity in immune thrombocytopenia (ITP)
Klaassen RJ, Young NL
Health-related quality of life outcomes for patients with immune thrombocytopenic purpura
Godeau B, Michel M
Treatment of chronic immune thrombocytopenic purpura in adults
Bolton-Maggs PHB, Kok VSL
Chronic immune thrombocytopenic purpurawho needs medication?
Kühne T, Imbach P
Eltrombopag: an update on the novel, non-peptide thrombopoietin receptor agonist for the treatment of immune thrombocytopenia
Jawa V, Hokom M et al.
Assessment of immunogenicity of romiplostim in clinical studies with ITP subjects
Wadenvik H, Olsson B
Moving towards a new era in the management of chronic immune thrombocytopenia
Bergmann AK, Grace RF, Neufeld EJ
Genetic studies in pediatric ITP: outlook, feasibility, and requirements
Kühne T
ICIS supplementum abstracts
Intercontinental Cooperative ITP Study Group (ICIS):
State of the Art Expert Meeting on ITP, September 23-25, 2003, Bürgenstock Switzerland
J Pediatr Hematol Oncol. 2003 Dec;25 Supplement 1
Imbach P et al.
Overview of the State of the Art Expert Meeting of the Intercontinental Cooperative ITP Study Group (ICIS)
Chanock S
The etiology of Childhood Immune Thrombocytopenic Purpura: How Complex Is It?
Semple J
Pathogenic T-Cell Responses in Patients with Autoimmune Thrombocytopenic Purpura
Crow AR,Lazarus A
The role of FcGamma Receptors in the Pathogenesis and Treatment of ITP
Kekomäki R
Platelet Function and Immune Response
Kühne T
Investigation and Management of Newly Diagnosed Childhood Idiopathic Thrombocytopenic Purpura: Problems and Proposed Solutions
Blanchette V,Price V
Childhood Chronic Immune Thrombocytopenic Purpura: Unresolved Issues
Provan D, Newland A
Immune Thrombocytopenic Purpura in Adults
Salama A
Alloimmune Thrombocytopenias
Buchanan G
Bleeding Signs in Children with Idiopathic Thrombocytopenic Purpura
Bolton-Maggs P
Severe Bleeding in Idiopathic Thrombocytopenic Purpura
Cines D et al.
Mechanisms of Action of Therapeutics in Idiopathic Thrombocytopenic Purpura
McMillan R
Antiplatelet Antibodies in Chronic Adult Immune Thrombocytopenic Purpura: Assays and Epitopes
Klaassen R
Using Decision Analysis Techniques to Deal With Unanswerable‘ Questions in Idiopathic Thrombocytopenic Purpura
Bullinger M et al.
Quality of Life in Children and Families with Bleeding Disorders
Imbach P et al.
Local and cultural Aspects of Childhood Idiopathic Thrombocytopenic Purpura: A Summary of Statements from the 12 Countries Worldwide
Imbach P et al.
New Developments in Idiopathic Thrombocytopenic Purpura: Cooperative, Prospective Studies by the Intercontinental Cooperative ITP Study Group
Freedman J
ITP: An Overview of the Conference and Future Directions with an Abbreviated ITP History